Abstract
The use of exercise testing is an important tool for the pediatric pulmonologist. Physical stress often reveals cardiorespiratory abnormalities that are not apparent on conventional static tests. There is little doubt the information acquired from exercise tests have diagnostic and prognostic value, but exercise tests may also be critical to determine success or failure of treatment strategies. The purpose of this chapter is to provide the pediatric specialist with an overview of exercise evaluation that may assist in the diagnosis of and management of disease in pediatric and adolescent patients with physical activity intolerance, especially those with cardiorespiratory diseases. The specific aims of this chapter are to: (1) describe various exercise tests and the biomechanical and physiological principles of those tests necessary to assess patients; (2) discuss methods to assess the physical fitness profile of patients with cardiorespiratory diseases and physical limitations; (3) provide specific strategies for an exercise prescription based on the fitness and clinical profile of the patient and; (4) assist the provider in developing a center for exercise evaluation. Although each aim provides unique information, the overall goal of this chapter is to stimulate the pediatric pulmonologist to develop an understanding of indications for cardiopulmonary exercise testing (CPET) and implement strategies to systematically assess each patient’s fitness profile; to track patient’s disease or training progression or alternatively to monitor responses of medical interventions; and to prescribe a well-rounded exercise prescription to maximize functional ability and wellness of individual patients. This chapter is not intended to be an in depth review for exercise physiologists, but is designed to assist the practicing clinician in the logistics of developing a program and a comfort in interpreting studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cooper DM, Radom-Aizik S, Shin H, Nemet D. Exercise and lung function in child health and disease. Kendig and Chernick’s disorders of the respiratory tract in children. Saunders 2012; Chapter 13, pp. 234–50.
Wasserman K, et al. Principles of exercise testing and interpretation. Williams & Wilkins: Lippincott; 2012.
Weisman IM, Marciniuk D, Martinez FJ, Sciurba F, Sue D, Myers J, et al. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167(2):211–77. http://www.ncbi.nlm.nih.gov/pubmed/12524257.
Pina IL, Balady GJ, Hanson P, Labovitz AJ, Madonna DW, Myers J. Guidelines for clinical exercise testing laboratories. A statement for healthcare professionals from the Committee on Exercise and Cardiac Rehabilitation, American Heart Association. Circulation. 1995;91(3):912–21. http://circ.ahajournals.org/content/91/3/912.full.
Morton AR. Exercise physiology. In: Pediatric respiratory medicine. 2nd edn. Elsevier Inc. 2008; p. 89–99. http://dx.doi.org/10.1016/B978–0–323–04048–8.50012–8.
Guazzi M, Adams V, Conraads V, Halle M, Mezzani A, Vanhees L, et al. EACPR/AHA Joint Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J. 2012;33(23):2917–27. http://www.ncbi.nlm.nih.gov/pubmed/22952138.
Roca J. Exercise testing (chapter 10). In: Clinical respiratory medicine. 4th ed. Elsevier Inc. 2010;143–53. http://dx.doi.org/10.1016/B978–1–4557–0792–8.00010–6.
Teoh OH, Trachsel D, Mei-Zahav M, Selvadurai H. Exercise testing in children with lung diseases. Paediatr Respir Rev. 2009;10:99–104.
Lipnowski S, LeBlanc CMA, Bridger TL, Houghton K, Philpott JF, Templeton CG, et al. Healthy active living: Physical activity guidelines for children and adolescents. Paediatr Child Health. 2012;17:209–10.
Han JC, Lawlor DA, Kimm SYS. Childhood obesity – 2010: progress and challenges. 2011;375(9727):1737–48.
Lattavo A, Kopperud A, Rogers PD. Creatine and other supplements. Pediatr Clin North Am. 2007;54:735–760 xi.
Maughan RJ, Greenhaff PL, Hespel P. Dietary supplements for athletes: emerging trends and recurring themes. J Sports Sci. 2011;29 Suppl 1:S57–66.
Samuels C. Sleep, recovery, and performance: the new frontier in high-performance athletics. Neurol Clin. 2008;26:169–80 ix–x.
Dement WC. Sleep extension: getting as much extra sleep as possible. Clin Sports Med. 2005;24:251–268 viii.
DeHass DM. NCAA study of substance use of college student-athletes. National Collegiate Athletic Association. 2006.
Tomporowski PD. Cognitive and behavioral responses to acute exercise in youths: a review. Pediatr Exercise Sci. 2003;15(4):348–59. http://journals.humankinetics.com/pes-back-issues/pes-back-issues/cognitiveandbehavioralresponsestoacuteexerciseinyouthsareview.
Ramos RP, Alencar MCN, Treptow E, Arbex F, Ferreira EM V, Neder JA. Clinical usefulness of response profiles to rapidly incremental cardiopulmonary exercise testing. Pulm Med. 2013;359021. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3666297&tool=pmcentrez&rendertype=abstract.
Ten Harkel ADJ, Takken T, Van Osch-Gevers M, Helbing WA. Normal values for cardiopulmonary exercise testing in children. Eur J Cardiovasc Prevent Rehabil. 2011;18:48–54.
LucĂa A, Fleck SJ, Gotshall RW, Kearney JT. Validity and reliability of the Cosmed K2 instrument. Int J Sports Med. 1993;14:380–6.
Skootsky SA, Abraham E. Continuous oxygen consumption measurement during initial emergency department resuscitation of critically ill patients. Crit Care Med. 1988;16:706–9.
Schrack JA, Simonsick EM, Ferrucci L. Comparison of the Cosmed K4b2 portable metabolic system in measuring steady-state walking energy expenditure. PLoS ONE. 2010;5:5.
Duffield R, Dawson B, Pinnington HC, Wong P. Accuracy and reliability of a Cosmed K4b2 portable gas analysis system. J Sci Med Sport. 2004;7:11–22.
Rowland TW. Oxygen uptake and endurance fitness in children: a developmental perspective. 1989.
Fisher M. Children and exercise: appropriate practices for grades K-6. JOPERD. 2009;80:18–23.
Hargreaves M. Fatigue mechanisms determining exercise performance: integrative physiology is systems biology. J Appl Physiol. 2008;104:1541–2.
Baker J, Côté J, Hawes R. The relationship between coaching behaviours and sport anxiety in athletes. J Sci Med Sport. 2000;3:110–9.
Birch SL, Duncan MJ, Franklin C. Overweight and reduced heart rate variability in British children: an exploratory study. Prev Med. 2012;55:430–2.
Walter LM, Foster AM, Patterson RR, Anderson V, Davey MJ, Nixon GM, et al. Cardiovascular variability during periodic leg movements in sleep in children. Sleep. 2009;32(8):1093–9. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2717200&tool=pmcentrez&rendertype=abstract.
Sookan T, McKune AJ. Heart rate variability in physically active individuals: reliability and gender characteristics. Cardiovasc J Afr. 2012;23(2):67–72. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3721889&tool=pmcentrez&rendertype=abstract.
Millar PJ, Rakobowchuk M, McCartney N, MacDonald MJ. Heart rate variability and nonlinear analysis of heart rate dynamics following single and multiple Wingate bouts. Appl Physiol Nutr Metab. 2009;34:875–83.
Gui-Ling X, Jing-Hua W, Yan Z, Hui X, Jing-Hui S, Si-Rui Y. Association of high blood pressure with heart rate variability in children. Iran J Pediatr. 2013;23(1):37–44. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3574990&tool=pmcentrez&rendertype=abstract.
McCain GC, Knupp AM, Fontaine JL, Pino LD, Vasquez EP. Heart rate variability responses to nipple feeding for preterm infants with bronchopulmonary dysplasia: three case studies. J Pediatr Nurs. 2010;25(3):215–20. http://www.ncbi.nlm.nih.gov/pubmed/20430282.
Yiallourou SR, Sands SA, Walker AM, Horne RSC. Maturation of heart rate and blood pressure variability during sleep in term-born infants. Sleep. 2012;35(2):177–86. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3250356&tool=pmcentrez&rendertype=abstract.
Lammers AE, Munnery E, Hislop AA, Haworth SG. Heart rate variability predicts outcome in children with pulmonary arterial hypertension. Int J Cardiol. 2010;142:159–65.
Scrogin K, Henze M, Hart D, Samarel A, Barakat J, Eckert L. Persistent alterations in heart rate variability, baroreflex sensitivity, and anxiety-like behaviors during development of heart failure in the rat. Am J Physiol Heart Circ Physiol. 2008;295:H29–38.
Ehrlén K. Drawings as representations of children’s conceptions. Int J Sci Educ. 2009;31:41–57.
Lau J, Engelen L, Bundy A. Parents’ perceptions of children’ s physical activity compared on two electronic diaries. Pediatr Exerc Sci. 2013;7:124–37.
Lau PWC, Fox KR, Cheung MWL. An analysis of sport identity as a predictor of children’ s participation in sport. Pediatr Exerc Sci. 2006;415–25.
Borg G. Borg’s perceived exertion and pain scales. Champaign: IL: Human Kinetics. 1998; 104. Available from The Free Library. http://www.thefreelibrary.com/Borg’s+Perceived+Exertion+and+Pain+Scales.-a053509933.Accessed 01 Sep 2014.
McGrath PJ, Pianosi PT, Unruh AM, Buckley CP. Dalhousie dyspnea scales: construct and content validity of pictorial scales for measuring dyspnea. BMC Pediatr. 2005;5:33.
Roemmich JN, Barkley JE, Epstein LH, Lobarinas CL, White TM, Foster JH. Validity of PCERT and OMNI walk/run ratings of perceived exertion. Med Sci Sports Exerc. 2006;38:1014–9.
Norton P, Hope D, Weeks J. The physical activity and sport anxiety scale (PASAS): Scale development and psychometric analysis. Anxiety Stress Coping. 2004;17:363–82.
Francis SE, Chorpita BF. Parental beliefs about child anxiety as a mediator of parent and child anxiety. Cogn Ther Res. 2009;35:21–9.
Powell CV, Primhak RA. Asthma treatment, perceived respiratory disability, and morbidity. Arch Dis Child. 1995;72:209–13.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Appendices
Case Studies
Case 1: CPRT Performed Pre-pectus Repair Nuss Bar
Patient 17 year old with Erlos-Danlos Syndrome.
Test variable | Predicted max | Rest | AT | AT2 | VO2 max (peak) |
RER | Â | 0.89 | 0.92 | Â | 0.98 |
Pulse O2 | 18 | 2 | 5 | 7 | 9 |
Work (Watts) | 306 | Â | 34 | 60 | 62 |
HHR% | Â | 100 | 85 | 78 | 75 |
BR% | Â | 95 | 92 | 87 | 81 |
HRR (bpm) | Â | 109 | 93 | 85 | 82 |
VO2 slope | – | – | – | – | – |
VO 2 pred (%) | Â | 6 | 14 | 22 | 32 |
HR pred (%) | Â | 47 | 55 | 59 | 60 |
Exer time (min) | Â | Â | 2 | 4 | 6 |
BP systolic | Â | 122 | Â | Â | 121 |
BP diastolic | Â | 81 | Â | Â | 75 |
PETO2 | Â | 108 | 106 | 105 | 108 |
PETCO2 | Â | 34 | 37 | 39 | 39 |
VO2 ml/kg/min | >35 | 3.6 | 8.2 | 12.9 | 18.9 |
HR bpm | 205 | 96 | 112 | 120 | 123 |
VECO2 | Â | 32 | 28 | 27 | 28 |
Vd/VT (estimated) | Â | 0.26 | 0.2 | 0.18 | 0.17 |
RR (br/min) | Â | Â | Â | Â | Â |
Variable checklist used to identify the pathophysiologic mechanism resulting in activity/exercise intolerance (N for normal range)
Variable | Y | N | H | L | Other |
VO2 max predicted attained or | Â | x | Â | Â | Â |
Maximum VO2 reached? | Â | x | Â | Â | Â |
Work load predicted from equations attained? | Â | x | Â | Â | Â |
Oxygen use high for work level | Â | x | Â | Â | Â |
Plateau of VO2 or heart rate with increasing work rate? | Â | x | Â | Â | Â |
RER maximal test (1.15)? | Â | x | Â | Â | Â |
Maximum HR predicted achieved? | Â | x | Â | Â | Â |
Max HR to low (sick heart-chronotropy)? | Â | x | Â | Â | Â |
Max HR too High (sick heart-inotropy)? | Â | x | Â | Â | Â |
ST segment displaced? | Â | x | Â | Â | Â |
Cardiac arrhythmias? | Â | x | Â | Â | Â |
Echocardiogram result | Â | x | Â | Â | Â |
Was the breathing reserve low (<20)? | Â | x | Â | Â | Â |
Was the breathing reserve normal or high? | x | Â | Â | Â | Â |
Dead space ventilation increase or decrease (VD/VT)? | Â | x | Â | Â | Â |
Oxygenation by (SaO2) normal | Â | x | Â | Â | Â |
Obese? | Â | x | Â | Â | Â |
Effort reason for stopping (if patient stopped) | Â | Â | Â | Â | Dyspnea fatigue |
Blood pressure increase appropriately? | Â | x | Â | Â | Â |
Is the patient a performance athlete? | Â | x | Â | Â | Â |
HRR normal? | Â | Â | Â | Â | Â |
HR1 (1 min postexercise)? | Â | Â | Â | Â | x |
HR2 (2 min postexercise)? | Â | Â | Â | Â | x |
Pulse O2 normal (rise and plateau)? | Â | x | Â | Â | Â |
VAT percent of VO2 (V-slope)? | Â | Â | Â | Â | x |
VE too high or VE too low? | Â | x | Â | Â | Â |
Variable | Result |
PETCO2 (no change) or VECO2 (increase) | Normal |
Breathing reserve low | No (high) |
VAT (ventilatory threshold) present | Yes low |
Pulse O2 | low |
Breathing reserve normal | High (normal) |
VAT present | low |
Cause-and-Effect Diagram Result (Case 1: Check All That Apply)
Conclusion: (check or circle)
-
Cardiac Limitation.
-
Respiratory Limitation.
-
Peripheral Vascular Limitation (PVD).
-
Pulmonary Hypertension (Circulation).
-
Metabolic Limitation.
-
Muscle Limitation.
-
Deconditioned.
-
Poor Effort.
Summary:
CPRT performed pre-pectus repair Nuss Bar.
Patient with Erlos-Danlos Syndrome.
The PETCO2 did not decrease, but VAT was achieved. The BR was normal. PaETO2 and VD/VT were normal as well. The pulse O2 was significantly low as was the VO2 max at levels seen in cardiomyopathies. The Echo results note a normal structured heart with good ejection fraction. Cardiac limitation likely from decrease left ventricular filling at higher (nonresting) level due to abnormal chest wall dynamics and decrease LV filling and stroke volumes at higher work levels. The patient is not physically fit.
Case 2: 14-year-old female complaints of dyspnea and inability to run cross country recent onset last 2 months.
Variable | Result |
PETCO2 decrease or VECO2 increase | Normal yes |
Breathing reserve low | Normal |
VAT (ventilatory threshold) present | Yes (early) |
Pulse O2 | Low |
Breathing reserve normal | Normal |
VAT present | Yes |
Suggest Cardiac Limitation
Other data:
-
VO2 max low
-
SaO2 low at max exercise
-
RR less than 50
-
HRR normal
-
Basal HR Slightly High for Age and Fitness Level (Runner)
-
Normal Chronotropic Response (80% of predicted maximal HR)
-
Hemoglobin 5.9
Cause-and-Effect Diagram Result (Case 2: Check All That Apply)
Conclusion: (check or circle) |
---|
° Cardiac limitation |
° Respiratory limitation |
° Peripheral vascular limitation (PVD) |
° Pulmonary hypertension (circulation) |
° Metabolic limitation |
° Muscle limitation |
° Deconditioned |
° Poor Effort |
° Anemia |
Summary:
Good Effort (RER . 1.15)
Additional History:
-
Complaints of dyspnea and inability to run cross country recent onset last 2 months.
-
Complete study with dyspnea at end, stopped complaining of fatigue, leg cramps, and dizziness. BP increase appropriately and the HRR reserve was normal though basal HR was increased. Leg Cramps likely from early VAT and low peripheral oxygen extraction at muscle level.
-
Pre-study same day pulmonary function tests pending calculation of DLCO
-
CBC reviewed (low hemoglobin)
-
SaO2 decrease likely secondary to increase oxygen extraction.
-
Exercise Intolerance secondary to anemia.
-
Additional History—teen with dysfunctional uterine bleeding menorrhagia for 4 months.
-
Diet vegetarian.
-
Sent to adolescent to reproductive health and iron indices ordered. sports nutrition discussed.
-
Primary care informed for follow-up.
Case 3: 22 year old prior 28 week premie born 1,088 g and did not receive surfactant. Bronchopulmonary dysplasia (BPD), intraventricular hemorrhage, osteopenia, and retinopathy of prematurity. College Student Masters Program Psychology.
Test variable | Predicted max | Rest | AT | AT2 | VO2 max (peak) |
RER | Â | Â | 0.85 | 1.04 | 1.28 |
Pulse O2 | 8 | 2 | 3 | 6 | 9 |
Work (Watts) | Â | Â | Â | Â | Â |
HHR% | Â | 100 | 101 | 30 | 28 |
BR% | Â | 92 | 91 | 50 | 37 |
HRR | 105 | 106 | 32 | 30 | 39 |
VO2 slope | Â | Â | Â | Â | Â |
VO2 pred (%) | Â | 13 | 15 | 62 | 91 |
HR pred (%) | Â | Â | Â | Â | Â |
Exer time | Â | 2 | 7 | 15 | 16 |
BP systolic | Â | Â | Â | Â | Â |
BP diastolic | Â | Â | Â | Â | Â |
PETO2 | Â | 106 | 107 | 124 | 121 |
PETCO2 | Â | 34 | 33 | 24 | 25 |
VO2 ml/kg/min | 38 | 5.1 | 5.7 | 23 | 34 |
HR bpm | 198 | 92 | 116 | 168 | 172 |
VE/VCO2 | 42 | 44 | 45 | 44 | 46 |
Vd/VT (estimated) | Â | 0.22 | 0.22 | 0.13 | 0.14 |
RR (br/min) | Â | 20 | 24 | 40 | 68 |
Variable | Result |
PETCO2 decrease or VECO2 increase | + |
Breathing reserve low | Normal |
VAT (ventilatory threshold) present | + |
Pulse O2 | Normal |
Breathing reserve normal | Normal |
VAT present | + |
Other data
-
VO2 ml/kg min−1 (normal).
-
RR > 50 at VO2 max.
-
FEV1 105 % predicted.
-
FVC 98 % predicted.
-
EKG normal during study.
Cause-and-Effect Diagram Result (Case 3: Check All That Apply)
Conclusion: (check or circle)
-
Cardiac limitation.
-
Respiratory limitation.
-
Peripheral vascular limitation (PVD).
-
Pulmonary hypertension (circulation).
-
Metabolic limitation.
-
Muscle limitation.
-
Deconditioned.
-
Poor effort.
-
None
Summary
Complains of chest pain with exercise
22 year old prior 28 week premie born 1,088 g and did not receive surfactant. Bronchopulmonary dysplasia (BPD), intraventricular hemorrhage, osteopenia, and retinopathy of prematurity. Gymnastics and Cheerleading at local university runs for exercise complaining of chest pain. Problems with cervical and thoracic scoliosis with secondary neuropathy manifest as pain, restless leg syndrome, and periodic limb movement disorder of sleep. Anxiety disorder and ADHD. Good student on medications
Medications:
-
1.
Pregbalin.
-
2.
Vyvanse.
-
3.
Adderall 7.5 mg prn once daily.
-
4.
Dulera two puffs twice a day.
Results:
There is no evidence of cardiopulmonary limitation. The VO2 max is normal and the cause-and-effect diagram is not valid in this case. The spirometry data shows no pre–post difference. However, the use of the cause-and effect-diagram does point out an interesting finding, at maximal work the RR was greater than 50 breaths-per-minute. If the VO2 was low and PETCO2 did not decrease and dead space ventilation not decrease, then respiratory limitation would be likely if the breathing reserve was low. The breathing reserve was normal and with the clinical history of BPD and prematurity pulmonary vascular disease should be considered. The dynamics of chest wall movement should also be considered due to the longstanding cervico-thoracic scoliosis. Exercise associated anxiety should also be entertained as the patient has a known issue.
Recommendations:
-
1.
Close follow-up and yearly CPET- Echo/EKG monitoring for evidence of pulmonary hypertension.
-
2.
Cognitive behavioral therapy for anxiety. Monitor scoliosis and associated neuropathy with sleep problems.
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Thomas, D., Credeur, D.P. (2015). Cardiopulmonary Exercise Testing Techniques to Evaluate Exercise Intolerance. In: Davis, S., Eber, E., Koumbourlis, A. (eds) Diagnostic Tests in Pediatric Pulmonology. Respiratory Medicine. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1801-0_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1801-0_12
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1800-3
Online ISBN: 978-1-4939-1801-0
eBook Packages: MedicineMedicine (R0)